Kevin Plancher
Orthopaedic Surgery · New York, NYNPI 1093765950
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Restor3d, Inc. at 32.5% of the total. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $980.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Restor3d, Inc.$63K
- Vertex$48K
- Pacira Pharmaceuticals Incorporated$28K
- Collagen Matrix, Inc$16K
- UOC USA Inc$10K
- Anika Therapeutics, Inc.$8K
- plus $20K from 30 others
Across 56 payments — averaging $7276.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aesculap Biologics, LLC$394K
- Anika Therapeutics, Inc.$14K
Across 1 payment — averaging $225,700 each. An ownership or investment interest held by the physician or an immediate family member.
- Restor3d, Inc.$226K
What the payments were for
- Consulting fees$107,28956%
- Speaking & faculty fees$58,90031%
- Travel & lodging$14,8488%
- Food & beverage$10,8316%
- Education$1,2001%
- Entertainment$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Restor3d, Inc. | 7 | $62,846 |
| Vertex | 46 | $47,596 |
| Pacira Pharmaceuticals Incorporated | 26 | $27,914 |
| Collagen Matrix, Inc | 5 | $16,329 |
| UOC USA Inc | 7 | $10,305 |
| Anika Therapeutics, Inc. | 9 | $7,783 |
| Aesculap Biologics, LLC | 29 | $3,225 |
| Zimmer Biomet | 5 | $2,610 |
| Heron Therapeutics, Inc. | 3 | $2,475 |
| Synthes GmbH | 3 | $2,460 |
| Bioventus LLC | 2 | $1,833 |
| Gotham Surgical Solutions & Devices, Inc. | 2 | $1,381 |
| Smith+Nephew | 14 | $1,066 |
| Averitas Pharma Inc. | 1 | $925 |
| Pacira Therapeutics, Inc. | 4 | $897 |
| Linvatec Corporation | 4 | $590 |
| Joint Restoration Foundation, Inc. | 1 | $400 |
| Stryker | 2 | $334 |
| Arthrex | 5 | $332 |
| Miach Orthopaedics, Inc. | 1 | $310 |
| Medacta USA, Inc. | 2 | $267 |
| Vericel Corporation | 3 | $236 |
| Geistlich Pharma, North America, Inc. | 1 | $160 |
| Conformis, Inc. | 1 | $152 |
| Catalyst Orthoscience | 1 | $128 |
| Orthalign Inc | 1 | $101 |
| Kuros Biosciences USA, Inc | 1 | $95 |
| Johnson & Johnson | 1 | $81 |
| Amgen | 3 | $58 |
| Biorez, Inc. | 1 | $46 |
| Trice Medical, Inc. | 1 | $44 |
| Kerecis Limited | 1 | $39 |
| Terumo BCT, Inc. | 1 | $29 |
| Tricoast Surgical Solutions LLC | 1 | $27 |
| Convatec Inc. | 1 | $16 |
| Medical Device Business Services, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JOURNAVX$46,799
- Zilretta$19,436
- EXPAREL$17,424
- TACTOSET$7,763
- U2, Conformity, U-Motion II and USTAR II$7,026
- Iovera$6,704
- U2, PSA, Conformity, UTS, U-Motion II and USTAR II$3,000
- NOVOCART 3D$2,544
- HTX-011$2,475
- Durolane$1,750
- Journey II$804
- REAL INTELLIGENCE$402
- BioBrace 23mm$295
- PRIMARY SHOULDER$267
- Bioinductive Implant with Arthroscopic Delivery System - Medium$263
- U-Star, Conformity, U2$188
- AEQUALIS PERFORM REVERSED$175
- Derma Gide$160
- AXSOS$160
- Identity Imprint Knee Replacement System$152
How this compares
$193,105 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 27 | $83 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.